title: In vivo assessment of hepatic triglycerides in murine non-alcoholic fatty liver disease using magnetic resonance spectroscopy.
abstract: In vivo(1)H magnetic resonance spectroscopy (MRS) was used to examine the progression of fatty liver in two murine models of progressive hepatic steatosis: leptin-deficient obese (ob/ob) mice and mice maintained on a diet deficient in methionine and choline (MCDD). Ob/ob mice displayed high levels of intracellular hepatic triglycerides as early as 9 weeks after birth, as observed with MRS and histopathology. Single voxel spectra of ob/ob liver displayed strong resonances arising from saturated (1.3 ppm) and unsaturated (2.8 and 5.3 ppm) fatty acyl chains that could be resolved in the absence of water suppression. Hepatic inflammation, induced by lipopolysaccharide administration, led to a significant increase in unsaturated and polyunsaturated fatty acyl chain resonances (P<0.05), indicating a change in the composition of hepatic triglycerides in lipid droplets. Mice maintained on the MCDD displayed histological evidence of hepatic steatosis as early as two weeks, progressing to macrovesicular steatohepatitis at 10 weeks. The histological changes were accompanied by significant increases in saturated and unsaturated fatty acyl chain resonances and a significant decrease in the lipid/(water+lipid) ratio (P<0.05). These results indicate that in vivo(1)H MRS may be a suitable method to monitor the progression of steatohepatitis.
authors.affiliation: Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA.
authors.forename: Ian R
authors.initials: IR
authors.lastname: Corbin
authors.forename: Emma E
authors.initials: EE
authors.lastname: Furth
authors.forename: Stephen
authors.initials: S
authors.lastname: Pickup
authors.forename: Evan S
authors.initials: ES
authors.lastname: Siegelman
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Delikatny
mesh_terms: D000438:Alcohols; D000818:Animals; D004032:Diet; D005227:Fatty Acids / Q000032:analysis; D005234:Fatty Liver / Q000378:metabolism* / Q000473:pathology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D008810:Mice, Inbred C57BL; D008820:Mice, Obese; D014280:Triglycerides / Q000378:metabolism*
chemical_list: D000438:Alcohols; D005227:Fatty Acids; D008070:Lipopolysaccharides; D014280:Triglycerides